Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke

Circulation

Volumn 98, Issue 25, 1998, Pages 2796-2799

  Ridker, Paul M ^a   Hennekens, Charles H ^a,b,c   Stampfer, Meir J ^a,c   Wang, Fred ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Atherosclerosis; Infection; Myocardial infarction; Stroke; Viruses

Indexed keywords

IMMUNOGLOBULIN G; VIRUS ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY RISK; CYTOMEGALOVIRUS INFECTION; FEMALE; HEART INFARCTION; HERPES SIMPLEX; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STROKE;

EID: 0032578973     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.25.2796     Document Type: Article

References (17)

1. Benditt EP, Barrett T, McDougall JK. Viruses in the etiology of atherosclerosis. Proc Null Acad Sci U S A. 1983;80:6386-6389.
2. Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation. 1997;96:4095-4103.
3. Melnick JL, Adam E, DeBakey ME. Possible role of cytomegalovirus in atherogenesis. JAMA. 1990;263:2204-2207.
4. Nieto FJ, Adam E, Sorlie P, Farzadegan H, Melnick JL, Comstock GW, Szklo M. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation. 1996;94:5:922-927.
5. Sorlie PD, Adam E, Melnick SL, Folsom A, Skelton T, Chambless LE, Barnes R, Melnick JL. Cytomegalovirus/herpesvirus and carotid atherosclerosis: the ARIC Study. J Med Virol. 1994;42:33-37.
6. Grattan MT, Moreno-Cabral CE, Staraes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA. 1989;261:3561-3566.
7. MacDonald K, Rector TS, Braunlan EA, Coubo SH, Olivori MT. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am J Pathol. 1989;64:359-362.
8. Gyorkey F, Melnick JL, Guinn GA, Gyuorkey P, DeBakey ME. Herpes viridae in the endothelial and smooth muscle cells of the proximal aorta of atherosclerotic patients. Exp Mol Pathol. 1984;40:328-339.
9. Hendrix MG, Salimans MM, van Boven CP, Bruggeman CA. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol. 1990;136:23-28.
10. Minick CR, Fabricant CG, Fabricant J, Litrenta MM. Atherosclerosis induced by infection with herpes virus. Am J Pathol. 1979;96:673-706.
11. Zhou YF, Leon MB, Waclawiw MA, Popma JJ, Yu ZM, Finkel T, Epstein SE. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med. 1996;335:624-630.
12. Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, Epstein SE. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science. 1994;265:391-394.
13. Steering Committee of the Physicians' Health Study Research Group. Final report of the aspirin component of the ongoing Physicians' Health Study. N Engl J Med. 1989;321:129-135.
14. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973-979.
15. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998;97:425-428.
16. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation. 1998;97:2007-2011.
17. Ridker PM. Inflammation, infection, and cardiovascular risk: how good is the clinical evidence? Circulation. 1998;97:1671-1674.